We are live on ! Find out more
JC

JBF Capital Portfolio holdings

AUM $764M Turnover 38.35%
1-Year Est. Return 24.26%
This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+24.26%
3 Year Est. Return
+93.63%
5 Year Est. Return
+127.41%
10 Year Est. Return
+469.69%
AUM
$647M
AUM Growth
+$34.8M
Cap. Flow
+$20.1M
Cap. Flow %
3.1%
Top 10 Hldgs %
77.97%
Holding
94
New
18
Increased
7
Reduced
9
Closed
11
Avg Time Held Equity + Options
1.9 years
Top 10 Avg Time Held Equity + Options
3.7 years
Top 20 Avg Time Held Equity + Options
2.5 years
Avg Time Held Equity only
1.9 years
Top 10 Avg Time Held Equity only
3.7 years
Top 20 Avg Time Held Equity only
2.5 years

Top Sells

Rank Stock Value
1
PBR icon
Petrobras
PBR
+$4.82M
2
INTC icon
Intel
INTC
+$4.42M
3
CRBG icon
Corebridge Financial
CRBG
+$3.45M
4
BHF icon
Brighthouse Financial
BHF
+$2.3M
5
UBS icon
UBS Group
UBS
+$1.61M

Sector Composition

Rank Sector Weight
1 Miscellaneous 42.85%
2 Technology 21.59%
3 Consumer Discretionary 19.48%
4 Energy 8.22%
5 Communication Services 2.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LU icon
76
Lufax Holding
LU
$766M
$130K 0.02%
55,000
-250,000
-82% -$953K
2021 Q4
10 quarters
OKUR icon
77
OnKure Therapeutics
OKUR
$86.3M
$121K 0.02%
8,000
– –
2023 Q4
2 quarters
IMA icon
78
ImageneBio Inc
IMA
$45.7M
$120K 0.02%
+6,054
New +$107K
2024 Q2
0 quarters
TKC icon
79
Turkcell
TKC
$4.34B
$114K 0.02%
15,000
-2,500
-14% -$16.4K
2021 Q1
13 quarters
VNDA icon
80
Vanda Pharmaceuticals
VNDA
$256M
$113K 0.02%
+20,000
New +$103K
2024 Q2
0 quarters
NOAH icon
81
Noah Holdings
NOAH
$505M
$106K 0.02%
+11,000
New +$136K
2024 Q2
0 quarters
ASXC icon
82
DELISTED
Asensus Surgical, Inc.
ASXC
$7.66K ﹤0.01%
+23,016
New +$6.21K
2024 Q2
0 quarters
MACK icon
83
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$1.19K ﹤0.01%
+39,637
New +$588K
2024 Q2
0 quarters
AMPY icon
84
Amplify Energy
AMPY
$180M
– –
-10,000
Closed -$66.1K –
BHF icon
85
Brighthouse Financial
BHF
$2.8B
– –
-44,700
Closed -$2.3M –
BLDR icon
86
Builders FirstSource
BLDR
$5.78B
– –
-1,000
Closed -$209K –
CNF icon
87
CNFinance Holdings
CNF
$33M
– –
-6,026
Closed -$125K –
CRBG icon
88
Corebridge Financial
CRBG
$15.3B
– –
-120,000
Closed -$3.45M –
INTC icon
89
Intel
INTC
$504B
– –
-100,000
Closed -$4.42M –
LEE icon
90
Lee Enterprises
LEE
$150M
– –
-83,921
Closed -$1.12M –
SQNS icon
91
Sequans Communications SA
SQNS
$38M
– –
-2,386
Closed -$23K –
UBS icon
92
UBS Group
UBS
$146B
– –
-52,500
Closed -$1.61M –
FUSN icon
93
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
– –
-25,000
Closed -$533K –
GTH
94
DELISTED
Genetron Holdings Limited ADS
GTH
– –
-81,900
Closed -$330K –

Similar funds

JBF Capital's Q2 2024 Portfolio in Review

As of Q2 2024, JBF Capital held 94 positions worth $647M, up 5.7% from $612M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

JBF Capital deployed $20.1M of net new capital in Q2 2024, opening 18 new positions and adding to 7 existing holdings. Its largest new stake was iShares Bitcoin Trust: 201,000 shares worth $6.86M.

By sector, the portfolio is most concentrated in Miscellaneous at 43% of assets, up from 42% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Petrobras, an estimated $4.82M trimmed.

  • JBF Capital's largest Q2 2024 buy was iShares Bitcoin Trust: 201,000 shares worth $6.86M.
  • JBF Capital added most to Dell in Q2 2024, an estimated $3.82M increase.
  • JBF Capital's biggest Q2 2024 reduction was Petrobras, cutting an estimated $4.82M.
  • JBF Capital fully exited Intel in Q2 2024, selling an estimated $4.42M.
  • JBF Capital's ten largest holdings make up 78% of its $647M portfolio in Q2 2024.
  • JBF Capital opened 18 new positions and closed 11 in Q2 2024.
  • JBF Capital's portfolio value rose 5.7% quarter-over-quarter to $647M.

Based on JBF Capital's 13F filing for Q2 2024, filed 8 Aug 2024.